Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol.

Koehl U, Brehm C, Huenecke S, Zimmermann SY, Kloess S, Bremm M, Ullrich E, Soerensen J, Quaiser A, Erben S, Wunram C, Gardlowski T, Auth E, Tonn T, Seidl C, Meyer-Monard S, Stern M, Passweg J, Klingebiel T, Bader P, Schwabe D, Esser R.

Front Oncol. 2013 May 17;3:118. doi: 10.3389/fonc.2013.00118. eCollection 2013.

2.

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).

Passweg JR, Pabst T, Blum S, Bargetzi M, Li Q, Heim D, Stussi G, Gregor M, Leoncini L, Meyer-Monard S, Brauchli P, Chalandon Y; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2014 Jan;55(1):87-91. doi: 10.3109/10428194.2013.790540. Epub 2013 May 2.

PMID:
23547838
3.

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers.

Stern M, Passweg JR, Meyer-Monard S, Esser R, Tonn T, Soerensen J, Paulussen M, Gratwohl A, Klingebiel T, Bader P, Tichelli A, Schwabe D, Koehl U.

Bone Marrow Transplant. 2013 Mar;48(3):433-8. doi: 10.1038/bmt.2012.162. Epub 2012 Sep 3.

PMID:
22941380
4.

Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashion.

Meyer-Monard S, Tichelli A, Troeger C, Arber C, de Faveri GN, Gratwohl A, Roosnek E, Surbek D, Chalandon Y, Irion O, Castelli D, Passweg J, Kindler V.

Cytotherapy. 2012 Feb;14(2):215-22. doi: 10.3109/14653249.2011.634404. Epub 2011 Dec 5.

PMID:
22136296
5.

Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.

Mueller RJ, Stussi G, Puga Yung G, Nikolic M, Soldini D, Halter J, Meyer-Monard S, Gratwohl A, Passweg JR, Odermatt B, Schanz U, Biedermann BC, Seebach JD.

Haematologica. 2011 Jan;96(1):119-27. doi: 10.3324/haematol.2010.030288. Epub 2010 Oct 7.

6.

Controversies in hybrid banking: attitudes of Swiss public umbilical cord blood donors toward private and public banking.

Manegold G, Meyer-Monard S, Tichelli A, Granado C, Hösli I, Troeger C.

Arch Gynecol Obstet. 2011 Jul;284(1):99-104. doi: 10.1007/s00404-010-1607-x. Epub 2010 Jul 24.

PMID:
20658141
7.

Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.

Siegler U, Meyer-Monard S, Jörger S, Stern M, Tichelli A, Gratwohl A, Wodnar-Filipowicz A, Kalberer CP.

Cytotherapy. 2010 Oct;12(6):750-63. doi: 10.3109/14653241003786155.

PMID:
20491532
8.

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

Adès L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, Recher C, Thomas X, Rayon C, Castaigne S, Tournilhac O, de Botton S, Ifrah N, Cahn JY, Solary E, Gardin C, Fegeux N, Bordessoule D, Ferrant A, Meyer-Monard S, Vey N, Dombret H, Degos L, Chevret S, Fenaux P; European APL Group.

Blood. 2010 Mar 4;115(9):1690-6. doi: 10.1182/blood-2009-07-233387. Epub 2009 Dec 17.

9.

Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood.

Rovó A, Stüssi G, Meyer-Monard S, Favre G, Tsakiris D, Heim D, Halter J, Arber C, Passweg J, Gratwohl A, Tichelli A.

Int J Lab Hematol. 2010 Jun;32(3):329-35. doi: 10.1111/j.1751-553X.2009.01185.x. Epub 2009 Aug 25.

10.

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

Zenhäusern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A.

Leuk Lymphoma. 2009 Sep;50(9):1501-11. doi: 10.1080/10428190903131755.

PMID:
19672771
11.

Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies.

Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C, Heim D, Passweg JR, Rischewski J, Paulussen M, Gratwohl A.

Bone Marrow Transplant. 2010 Jan;45(1):103-9. doi: 10.1038/bmt.2009.123. Epub 2009 Jun 29.

PMID:
19561651
12.

Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Adès L.

J Clin Oncol. 2009 Jun 1;27(16):2668-76. doi: 10.1200/JCO.2008.18.4119. Epub 2009 May 4.

PMID:
19414681
13.

Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.

Meyer-Monard S, Passweg J, Siegler U, Kalberer C, Koehl U, Rovó A, Halter J, Stern M, Heim D, Alois Gratwohl JR, Tichelli A.

Transfusion. 2009 Feb;49(2):362-71. doi: 10.1111/j.1537-2995.2008.01969.x.

PMID:
19389215
14.

Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.

Zenhäusern R, Von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2009 Jan;50(1):133-6. doi: 10.1080/10428190802527681. No abstract available.

PMID:
19152171
15.

Aplastic anemia and concomitant autoimmune diseases.

Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber C, Buser A, Meyer-Monard S, Tichelli A, Gratwohl A.

Ann Hematol. 2009 Jul;88(7):659-65. doi: 10.1007/s00277-008-0671-9. Epub 2009 Jan 13.

PMID:
19139895
16.

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells.

Meyer-Monard S, Passweg J, Troeger C, Eberhard HP, Roosnek E, de Faveri GN, Chalandon Y, Rovo A, Kindler V, Irion O, Holzgreve W, Gratwohl A, Müller C, Tichelli A, Tiercy JM.

Bone Marrow Transplant. 2009 May;43(10):771-8. doi: 10.1038/bmt.2008.391. Epub 2008 Dec 8.

PMID:
19060930
17.

Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study.

Kohlmann A, Haschke-Becher E, Wimmer B, Huber-Wechselberger A, Meyer-Monard S, Huxol H, Siegler U, Rossier M, Matthes T, Rebsamen M, Chiappe A, Diemand A, Rauhut S, Johnson A, Liu WM, Williams PM, Wieczorek L, Haferlach T.

Clin Chem. 2008 Oct;54(10):1705-15. doi: 10.1373/clinchem.2008.108506. Epub 2008 Aug 21.

18.

Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.

Birrer A, Jusufi F, Bernimoulin M, Tichelli A, Gratwohl A, Nissen-Druey C, Dirnhofer S, Meyer-Monard S, Stern M.

Eur J Haematol. 2008 Oct;81(4):267-72. doi: 10.1111/j.1600-0609.2008.01115.x. Epub 2008 Jul 8.

PMID:
18616511
19.

Patient and product factors affecting platelet transfusion results.

Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S, Halter J, Tichelli A, Gratwohl A.

Transfusion. 2008 Apr;48(4):681-7. doi: 10.1111/j.1537-2995.2007.01613.x. Epub 2008 Jan 15.

PMID:
18208413
20.

Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood.

Manegold G, Meyer-Monard S, Tichelli A, Pauli D, Holzgreve W, Troeger C.

Transfusion. 2008 May;48(5):871-6. doi: 10.1111/j.1537-2995.2007.01617.x. Epub 2008 Jan 15.

PMID:
18208410
21.

Upregulation of MEL1 and FLJ42875 genes by position effect resulting from a t(1;2)(p36;p21) occurring during evolution of chronic myelomonocytic leukemia.

Storlazzi CT, Albano F, Guastadisegni MC, Impera L, Mühlematter D, Meyer-Monard S, Wuillemin W, Rocchi M, Jotterand M.

Blood Cells Mol Dis. 2008 May-Jun;40(3):452-5. doi: 10.1016/j.bcmd.2007.11.004. Epub 2008 Feb 21. No abstract available.

PMID:
18178491
22.

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.

Adès L, Sanz MA, Chevret S, Montesinos P, Chevallier P, Raffoux E, Vellenga E, Guerci A, Pigneux A, Huguet F, Rayon C, Stoppa AM, de la Serna J, Cahn JY, Meyer-Monard S, Pabst T, Thomas X, de Botton S, Parody R, Bergua J, Lamy T, Vekhoff A, Negri S, Ifrah N, Dombret H, Ferrant A, Bron D, Degos L, Fenaux P.

Blood. 2008 Feb 1;111(3):1078-84. Epub 2007 Nov 1.

23.

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.

Tichelli A, Bucher C, Rovó A, Stussi G, Stern M, Paulussen M, Halter J, Meyer-Monard S, Heim D, Tsakiris DA, Biedermann B, Passweg JR, Gratwohl A.

Blood. 2007 Nov 1;110(9):3463-71. Epub 2007 Jul 30.

24.

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.

Pogacic V, Bullock AN, Fedorov O, Filippakopoulos P, Gasser C, Biondi A, Meyer-Monard S, Knapp S, Schwaller J.

Cancer Res. 2007 Jul 15;67(14):6916-24.

25.

Role of primacy of birth in HLA-identical sibling transplantation.

Bucher C, Stern M, Buser A, Heim D, Paulussen M, Halter J, Tsakiris D, Droll A, Meyer-Monard S, Tichelli A, Passweg J, Gratwohl A.

Blood. 2007 Jul 1;110(1):468-9. No abstract available.

26.

High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.

Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G, Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A.

Bone Marrow Transplant. 2007 Mar;39(6):335-40.

PMID:
17342158
27.

Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.

Adès L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Maloisel F, Deconinck E, Ferrant A, Thomas X, Fegueux N, Chomienne C, Dombret H, Degos L, Fenaux P; European Acute Promyelocytic Leukemia Group.

J Clin Oncol. 2006 Dec 20;24(36):5703-10. Epub 2006 Nov 20.

PMID:
17116939
28.

Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.

Stern M, Passweg J, Tiercy JM, Genitsch A, Meyer-Monard S, Heim D, Tichelli A, Gratwohl A, Nissen-Druey C.

Biol Blood Marrow Transplant. 2006 Nov;12(11):1169-75.

29.

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

Passweg JR, Koehl U, Uharek L, Meyer-Monard S, Tichelli A.

Best Pract Res Clin Haematol. 2006;19(4):811-24. Review.

PMID:
16997185
30.

[Genetic diagnosis of acute leukemias--a practical guide].

Meyer-Monard S.

Ther Umsch. 2006 Apr;63(4):237-42. Review. German.

PMID:
16689453
31.

Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.

Rovó A, Tichelli A, Passweg JR, Heim D, Meyer-Monard S, Holzgreve W, Gratwohl A, De Geyter C.

Blood. 2006 Aug 1;108(3):1100-5. Epub 2006 Mar 16.

32.

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).

Kelaidi C, Ades L, Chevret S, Sanz M, Guerci A, Thomas X, de Botton S, Raffoux E, Rayon C, Fegueux N, Bordessoule D, Rigal-Huguet F, Link H, Stoppa A, Vekhoff A, Meyer-Monard S, Castaigne S, Dombret H, Degos L, Fenaux P.

Leukemia. 2006 May;20(5):905-7. No abstract available.

PMID:
16541143
33.

Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia.

Heim D, Friess D, Christen S, Stüssi G, Meyer-Monard S, Tichelli A, Passweg JR, Gratwohl A.

Leukemia. 2006 May;20(5):898-900. No abstract available.

PMID:
16525490
34.

Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia.

Meyer-Monard S, Parlier V, Passweg J, Mühlematter D, Hess U, Bargetzi M, Kühne T, Cabrol C, Gratwohl A, Jotterand M, Tichelli A.

Leukemia. 2006 Feb;20(2):247-53.

PMID:
16408102
35.

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.

Siegler U, Kalberer CP, Nowbakht P, Sendelov S, Meyer-Monard S, Wodnar-Filipowicz A.

Leukemia. 2005 Dec;19(12):2215-22.

PMID:
16224486
36.

No evidence of plasticity in hair follicles of recipients after allogeneic hematopoietic stem cell transplantation.

Rovó A, Meyer-Monard S, Heim D, Arber C, Passweg JR, Gratwohl A, Tichelli A.

Exp Hematol. 2005 Aug;33(8):909-11.

PMID:
16038783
37.

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.

Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, Thomas X, Guerci A, Fegueux N, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Ferrand A, Sanz M, Chomienne C, Fenaux P, Dombret H; European APL Group.

Leukemia. 2005 Jul;19(7):1153-60.

PMID:
15889156
38.

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16).

Helbling D, Mueller BU, Timchenko NA, Schardt J, Eyer M, Betts DR, Jotterand M, Meyer-Monard S, Fey MF, Pabst T.

Blood. 2005 Aug 15;106(4):1369-75. Epub 2005 Apr 26.

39.

Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript.

Meyer-Monard S, Mühlematter D, Streit A, Chase AJ, Gratwohl A, Cross NC, Jotterand M, Tichelli A.

Leukemia. 2005 Jun;19(6):1096-9. No abstract available.

PMID:
15789067
40.

Human hematopoietic colonies in health and disease.

Nissen-Druey C, Tichelli A, Meyer-Monard S.

Acta Haematol. 2005;113(1):5-96. No abstract available.

PMID:
15631142
41.

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.

Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kühne T, Favre G, Gratwohl A.

Leukemia. 2004 Nov;18(11):1835-8.

PMID:
15457184
42.

The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.

Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S, Lister A, Rowley JD, Huegli B, Fey MF, Pabst T.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13312-7. Epub 2004 Aug 23.

43.

Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.

Beyer V, Castagné C, Mühlematter D, Parlier V, Gmür J, Hess U, Kovacsovics T, Meyer-Monard S, Tichelli A, Tobler A, Jacky E, Schanz U, Bargetzi M, Hagemeijer A, de Witte T, van Melle G, Jotterand M.

Cancer Genet Cytogenet. 2004 Jul 1;152(1):29-41.

PMID:
15193439
44.

Complete remission of alopecia universalis after allogeneic hematopoietic stem cell transplantation.

Seifert B, Passweg JR, Heim D, Rovó A, Meyer-Monard S, Buechner S, Tichelli A, Gratwohl A.

Blood. 2005 Jan 1;105(1):426-7. Epub 2004 Apr 8.

45.

G-CSF for imatinib-induced neutropenia.

Heim D, Ebnöther M, Meyer-Monard S, Tsakiris D, Linn M, Tichelli A, Gratwohl A.

Leukemia. 2003 Apr;17(4):805-7. No abstract available.

PMID:
12682643
46.

Determination of the donor:host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphisms.

Wicki A, Malik N, Gratwohl A, Tichelli A, Meyer-Monard S, Müller H.

Swiss Med Wkly. 2002 Jun 1;132(21-22):288-95.

PMID:
12362287
47.

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation.

Passweg JR, Meyer-Monard S, Gregor M, Favre G, Heim D, Ebnoether M, Tichelli A, Gratwohl A.

Bone Marrow Transplant. 2002 Sep;30(5):267-71.

48.

A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL).

Novak U, Oppliger Leibundgut E, Hager J, Mühlematter D, Jotterand M, Besse C, Leupin N, Ratschiller D, Papp J, Kearsey G, Aebi S, Graber H, Jaggi R, Lüthi JM, Meyer-Monard S, Lathrop M, Tobler A, Fey MF.

Blood. 2002 Sep 1;100(5):1787-94.

49.

Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.

Da Silva N, Meyer-Monard S, Menot ML, Parrado A, Lebel A, Balitrand N, Fenaux P, Micléa JM, Rousselot P, Degos L, Dombret H, Chomienne C.

Hematol J. 2000;1(5):316-28.

PMID:
11920209
50.

The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patients.

Schwaller B, Meyer-Monard S, Gander JC, Pugin P, Celio MR, Ludwig C.

Anticancer Res. 1998 Sep-Oct;18(5B):3661-7.

PMID:
9854474

Supplemental Content

Loading ...
Support Center